# ELELYSO

NDC: 0069-0106
Generic name: Taliglucerase alfa
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20120501

FDA application: BLA022458

## Active ingredients

- TALIGLUCERASE ALFA: 200 U/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0069-0106"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-0106
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fa3cbd5d-677c-4b19-9032-d9182cb69a83